Iovance Biotherapeutics (IOVA) Net debt US GAAP (year values)

FY2021 FY2022 FY2023 FY2024 FY2025   LTM ? CAGR 5 years ?
Net debt, bln rub -432.9 -386.4 -204.0 -265.5 -248.5   -266.7  
Changes by years, y/y, % -25% -11% -47% +30% -6%     -15.5%

Iovance Biotherapeutics. Net debt, bln rub

Iovance Biotherapeutics. Net debt, changes, %

Iovance Biotherapeutics (IOVA) Net debt US GAAP (quarter values)

FY2025Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2026Q1   LTM ?
Net debt, bln rub -306.0 -248.0 -248.3 -248.5 -265.7   -266.7
Changes by years, y/y, % +13% -25% -22% -6% -13%    
Changes by quarters, q/q, % +15% -19% +0% +0% +7%    

Iovance Biotherapeutics. Net debt, bln rub

Iovance Biotherapeutics. Net debt, changes, y/y, %

Iovance Biotherapeutics. Net debt, changes, q/q, %